New Medical Campus center hopes to speed development of interventions and cures BU has launched a five-year translational research alliance with Johnson & Johnson Innovation LLC (JJI) aimed at preventing, intercepting, and curing lung cancer, the leading cause of cancer deaths worldwide. As part of the new alliance, JJI will fund a Johnson & Johnson Innovation Lung […]
Featuring Keynote Speaker Nobel Laureate Professor Stefan Hell On May 2, 2017, BUnano held its inaugural symposium, “Nanotechnology for Imaging,” which focused on highlighting accomplishments of BUnano faculty and students, and featured keynote presentation by 2014 Nobel Prize winner for Chemistry, Professor Stefan Hell.
Boston University researchers Professor Béla Suki (left) and TRB Fellow Jarred Mondoñedo have developed a computer model of emphysema that could help predict patient survival and quality of life following treatment. Their model suggests that a less-invasive treatment called bronchoscopic lung volume reduction (bLVR) performs as well as, or better than, traditional lung volume reduction surgery, […]
A new nasal test may allow patients suspected of having lung cancer to undergo a simple swab of their nose to determine if they have the disease. Avi Spira and Marc Lenburg at Boston University School of Medicine (BUSM) have found that a genomic biomarker in the nasal passage can accurately determine the likelihood that a lung lesion […]
ENTREPRENEURSHIP AND YOU Monday, February 27, 2017 | 1:30-3 p.m. Photonics Colloquium Room 8 St. Mary’s Street, 9th Floor Featuring Jill Becker, Entrepreneur in Residence, BUnano, Michael Koeris, Biomedical Engineering alumnus and CEO and Founder, Sample6, and Deckard Sorensen, Founder, NBD Nanotechnologies, Inc. Boston University is part of Boston’s strong entrepreneurial community and ecosystem — […]